Literature DB >> 28923223

An Update on Randomized Clinical Trials in Hepatocellular Carcinoma.

Hao-Wen Sim1, Jennifer Knox1, Laura A Dawson2.   

Abstract

Hepatocellular carcinoma is a common malignancy that typically occurs in the setting of comorbid liver disease. Optimal management is challenging, especially given the assortment of available treatment modalities. This article reviews the randomized clinical trials that have formed the basis of contemporary hepatocellular carcinoma management.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Evidence-based medicine; Hepatocellular carcinoma; Management; Randomized trials; Review

Mesh：

Substances：

Year:  2017        PMID： 28923223     DOI： 10.1016/j.soc.2017.05.006

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN： 1055-3207            Impact factor:   3.495


  3 in total

1.  Real-time Magnetic Resonance-guided Liver Stereotactic Body Radiation Therapy: An Institutional Report Using a Magnetic Resonance-Linac System.

Authors:  Aharon M Feldman; Ankit Modh; Carri Glide-Hurst; Indrin J Chetty; Benjamin Movsas
Journal:  Cureus       Date:  2019-09-26

2.  Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Tumors: Initial Clinical Experience and Patient-Reported Outcomes.

Authors:  Fabian Weykamp; Philipp Hoegen; Sebastian Klüter; C Katharina Spindeldreier; Laila König; Katharina Seidensaal; Sebastian Regnery; Jakob Liermann; Carolin Rippke; Stefan A Koerber; Carolin Buchele; Jürgen Debus; Juliane Hörner-Rieber
Journal:  Front Oncol       Date:  2021-06-09       Impact factor: 6.244

3.  Silence of Stomatin-Like Protein 2 Represses Migration and Invasion Ability of Human Liver Cancer Cells via Inhibiting the Nuclear Factor Kappa B (NF-κB) Pathway.

Authors:  Wenyu Zhu; Wei Li; Qian Geng; Xiaoying Wang; Wei Sun; Hua Jiang; Xiaolin Pu
Journal:  Med Sci Monit       Date:  2018-10-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.